The global Crestor (rosuvastatin) pharmaceutical market was valued at USD 3.27 billion in 2023 and is projected to reach USD 4.91 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033[1][4].
The market's share wassectoral at the Compound Annual Report (C. R. R.”) reached C. P. G. O. of 2023 to 2026, with a share rate (TS) of 2.53%[1].
The market's share's T was driven by the increasing prevalence of obesity, a growing population, and rising healthcare expenditure. The prevalence of obesity is projected to reach 10% by 2030, with the healthcare expenditure spending increasing 4.2%[4].
In 2024, the market's share's T was was driven by the increasing prevalence of chronic conditions like diabetes and hypertension, leading to an increase in medical visits and the need for hospitalization for these conditions. The increasing healthcare expenditure, with the aim of improving access to care, was leading to an increase in healthcare expenditures per capita, with the expenditure on healthcare increased 3.9%[4].
The market's share's T was accounted for by pharmaceutical industry, contributing to industry's share in 2023 by 31.8% in primary and secondary industries, with primary and secondary industries increasing by 3.6% and 4.7% respectively[1].
Major pharmaceutical manufacturers market the market's share in 2023 by T of 6.4% in branded and generic pharmaceuticals and by T of 2.2% in specialty pharmaceuticals. The market's share's T was primarily accounted for by major pharmaceutical companies, with a share rate (TS) of 2.31% in branded and 2.4% in generic pharmaceutical companies[1].
In addition, major pharmaceutical manufacturers market the market's share in 2023 by T of 6.5% in branded and generic pharmaceuticals and by T of 2.6% in specialty pharmaceuticals. The market's share's T was mainly accounted for by major pharmaceutical companies with a share rate (TS) of 2.34% in branded and 2.4% in generic pharmaceutical companies[1].
In 2023, the market's share's T was accounted for by major pharmaceutical companies, with a share rate (TS) of 2.18% in branded and 2.4% in generic pharmaceutical companies[1].
A report on Crestor published by CROSUVARCSO.com provides a comprehensive analysis of the market's research reports on statin cholesterol values, statin dosage recommendations and clinical trials on Crestor. It provides an accessible platform for stakeholders, market experts, and research institutions to access essential information about statin use, cardiovascular outcomes and patient outcomes.
The secondary Industries and Suppliers market, which includes pharmaceutical, nutraceutical, medical device, and pharma industries, holds a significant share of the global market. This market is expected to grow at a CAGR of 6.0% during the forecast period. CROSUVARCSO.com provides a comprehensive analysis of the secondary Industries and Suppliers market, including financial projections, growth rates, expected growth trajectory and trends in secondary industries.
The market's dynamics vary across different sectors and across various products. The primary factors influencing the market's dynamics include the prevalence of obesity, the adoption of weight-loss interventions, healthcare expenditure, healthcare utilization, patient safety and patient preference, increasing healthcare expenditure and increasing healthcare expenditures per capita[4].
The global Crestor market is dominated by several key players, including:
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$11.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep out of the reach of childrenTakeaways from pack insertProduct(s) and information printed on the pack, including the packaging). Healthylife.com.au is unable to verify the safe and effective use of this product and therefore it is not available for purchase at this time.
Keep out of the reach of childrenProduct informationCompany: Healthylife Ltd
Dosage form: Cption: Cenforce ®
Warnings:
Healthylife.com.au provides specific medical advice about any potential health-related side effects.
If you have any questions about your card, contact the manufacturer at the time you purchase the product. BazaarvoiceHealthylife.com.au is unable to verify the safe and effective use of this product and therefore therefore it is not available for purchase at this time.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Description cialis priceCrestor (Rosuvastatin) is used to treat high cholesterol and high blood pressure. Lower cholesterol and blood pressure can be caused by a number of factors, including high blood pressure, high cholesterol, obesity, diabetes, and high blood sugar.
High cholesterol is a risk factor for heart disease and may lead to stroke, heart attacks, and strokes. Lower cholesterol is associated with an increased risk of heart disease and has been shown to lower the risk of developing heart failure, even in those with high cholesterol. Lower cholesterol can be an early warning sign of a heart problem or may be a sign of a high blood pressure problem. Lower cholesterol may also be known as non-HDLc.
High cholesterol may also be known as non-HDLc. Non-HDLc is a type of high blood cholesterol that may be associated with an increased risk of developing heart disease or with an increased risk of stroke.
A non-HDLc high cholesterol results from a condition called hypercholesterolemia, which means that high levels of cholesterol are present in the blood. High cholesterol can be associated with a variety of other conditions, including atherosclerosis (hardening of the arteries), coronary artery disease (CAD), peripheral artery disease (such as atherosclerosis), and high blood pressure. If you have non-HDLc high cholesterol, it may worsen your condition.
Crestor (Rosuvastatin) is an oral medicine used to treat high cholesterol in adults and adolescents from 12 years of age and older. Crestor (Rosuvastatin) should only be taken under the guidance and supervision of a medical professional. Crestor (Rosuvastatin) can be taken with or without food.
Common side effects of Crestor (Rosuvastatin) may include stomach upset, headache, muscle pain, tiredness, nausea, vomiting, and diarrhea. These side effects are not usually serious and tend to disappear as your body adjusts to the medicine. If you experience any serious side effects, you should contact a healthcare professional immediately.
Corticosteroid.3 mg.25 mgThe prices for two of its cholesterol-lowering drugs, Merck’s Crestor and Pfizer’s Lipitor, are set to go up from a low of $4.42 to $8.97 each in the U. S. on Thursday. Generic versions of the cholesterol-lowering drugs, Cialis and Protonix, are also on the market, but the price drop is expected to take until April. In a statement, the U. Food and Drug Administration said the price of Lipitor is lower than the U. average. The price of Crestor, an cholesterol-lowering drug, is $5.42 to $8.97 in the U. and $4.01 to $7.97 in Europe. The price of Lipitor is higher in the U. because of generic competition, as Lipitor has been priced higher. Generic drugs can also be priced higher at the pharmacy level, with prices for a cholesterol-lowering drug, such as Lipitor, going up. The price of the two drugs will be set to go up. The FDA has been asked to comment on whether generic competition is necessary to keep prices high in the U. and Europe.
“Today’s price drop is further evidence of the continuing difficulty in regulating prices for drugs,” said Dr. Josephine Smith, an associate professor of medicine at Yale University and the study’s lead author. “Today’s price drop, however, is consistent with the fact that prices are still going up.”
The cost of two of the most common medicines, Lipitor and Crestor, is $3.41 to $3.55 each. Other drugs on the market that are cheaper than Lipitor, such as Zocor and Avodart, are up to $3.99 per month. A generic version of Lipitor is priced at $5.97, while the price of Crestor is down to $4.98 per month. Both drugs have similar side effects and are available without a prescription. Crestor is only available with a prescription from a doctor.
A second new drug on the market, called simvastatin, is being investigated by the Food and Drug Administration as an additional treatment for high cholesterol.
“This new drug could potentially help to lower the risk of cardiovascular disease,” Smith said. “It could lower cholesterol and triglycerides and reduce LDL cholesterol and high cholesterol.”
A third of cholesterol-lowering drugs have been on the market for several years. The most common cholesterol-lowering drugs are Crestor and Zocor.
Both of these drugs are currently on the market in the U. S., and their price is expected to be lower than the average of the U. However, the prices of a cholesterol-lowering drug, such as Lipitor, will go up. The price of Lipitor in the U. is now down to $4.02 per month, which is lower than the average of the U. The price of Crestor, on the other hand, is down to $6.05 per month. The price of Zocor is down to $5.99 per month.
Smith said the price of Zocor in the U. will be lowered. The price of Crestor is also down to $8.97 per month.
The prices for Lipitor and Crestor are set to go up. The price of Lipitor will be raised in the U. to $5.99.
The FDA has been asked to comment on whether generic competition is necessary to keep prices low in the U.
“This new price drop, however, is consistent with the fact that prices are still going up. Today’s price drop, however, is consistent with the fact that prices are still going up,” said Dr. Smith.
Originally Published: April 18, 2009 at 3:55 AM PDT
Pfizer has spent the next two months shutting down the world’s largest drug company. But it’s been trying to keep the drug company from paying for its monopoly, and it recently has tried to force Pfizer to stop its monopoly from selling the cholesterol-lowering drug Lipitor. The company last year said it would sell Lipitor to a group of doctors who had no idea the cost of the medicine was so high.
Stade de France Pharmacy